Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices.

Martín C, Cardona AF, Zatarain-Barrón ZL, Ruiz-Patiño A, Castillo O, Oblitas G, Corrales L, Lupinacci L, Pérez MA, Rojas L, González L, Chirinos L, Ortíz C, Lema M, Vargas C, Puparelli C, Carranza H, Otero J, Arrieta O.

Oncology. 2018;94(5):297-305. doi: 10.1159/000486862. Epub 2018 Mar 6.

PMID:
29510386
2.

Building Better Environmental Risk Assessments.

Layton R, Smith J, Macdonald P, Letchumanan R, Keese P, Lema M.

Front Bioeng Biotechnol. 2015 Aug 6;3:110. doi: 10.3389/fbioe.2015.00110. eCollection 2015. Review.

3.

In vitro activity of glucosinolates and their degradation products against brassica-pathogenic bacteria and fungi.

Sotelo T, Lema M, Soengas P, Cartea ME, Velasco P.

Appl Environ Microbiol. 2015 Jan;81(1):432-40. doi: 10.1128/AEM.03142-14. Epub 2014 Oct 31.

4.

How adolescents learn about risk perception and behavior in regards to alcohol use in light of social learning theory: a qualitative study in Bogotá, Colombia.

Trujillo EM, Suárez DE, Lema M, Londoño A.

Int J Adolesc Med Health. 2015 Feb;27(1):3-9. doi: 10.1515/ijamh-2014-0003.

PMID:
24864297
5.

Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia.

Hernández JE, Llacuachaqui M, Palacio GV, Figueroa JD, Madrid J, Lema M, Royer R, Li S, Larson G, Weitzel JN, Narod SA.

Hered Cancer Clin Pract. 2014 Apr 17;12(1):11. doi: 10.1186/1897-4287-12-11. eCollection 2014.

6.

Terms used for people living with HIV in the Democratic Republic of the Congo.

Mupenda B, Duvall S, Maman S, Pettifor A, Holub C, Taylor E, Rennie S, Kashosi M, Lema M, Behets F.

Qual Health Res. 2014 Feb;24(2):209-16. doi: 10.1177/1049732313519869. Epub 2014 Jan 24.

7.

In vivo and in vitro effects of secondary metabolites against Xanthomonas campestris pv. campestris.

Velasco P, Lema M, Francisco M, Soengas P, Cartea ME.

Molecules. 2013 Sep 11;18(9):11131-43. doi: 10.3390/molecules180911131.

8.

Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain.

Graus F, Bruna J, Pardo J, Escudero D, Vilas D, Barceló I, Brell M, Pascual C, Crespo JA, Erro E, García-Romero JC, Estela J, Martino J, García-Castaño A, Mata E, Lema M, Gelabert M, Fuentes R, Pérez P, Manzano A, Aguas J, Belenguer A, Simón A, Henríquez I, Murcia M, Vivanco R, Rojas-Marcos I, Muñoz-Carmona D, Navas I, de Andrés P, Mas G, Gil M, Verger E.

Neuro Oncol. 2013 Jun;15(6):797-805. doi: 10.1093/neuonc/not013. Epub 2013 Mar 3.

9.

[Atypical presentation of esthesioneuroblastoma].

Costa-Arpin E, Ares-Pensado B, Lopez-Ferreiro A, Prieto JM, Lema M.

Rev Neurol. 2012 Jun 16;54(12):765-7. Spanish. No abstract available.

10.

When does acute pain become chronic?

Voscopoulos C, Lema M.

Br J Anaesth. 2010 Dec;105 Suppl 1:i69-85. doi: 10.1093/bja/aeq323. Review.

11.

Resistance of cabbage (Brassica oleracea capitata group) crops to Mamestra brassicae.

Cartea ME, Francisco M, Lema M, Soengas P, Velasco P.

J Econ Entomol. 2010 Oct;103(5):1866-74.

PMID:
21061991
12.

Comprehensive lung injury pathology induced by mTOR inhibitors.

Aparicio G, Calvo MB, Medina V, Fernández O, Jiménez P, Lema M, Figueroa A, Antón Aparicio LM.

Clin Transl Oncol. 2009 Aug;11(8):499-510.

PMID:
19661024
13.

[Clinical course of multiple sclerosis in patients treated with cytostatic drugs for cancer].

Santos-García D, Prieto JM, Lema M.

Rev Neurol. 2009 Jan 16-31;48(2):71-4. Spanish.

14.

Clinical picture of a patient with a novel PSEN1 mutation (L424V).

Robles A, Sobrido MJ, García-Murias M, Prieto JM, Lema M, Santos D, Paramo M.

Am J Alzheimers Dis Other Demen. 2009 Feb-Mar;24(1):40-5. doi: 10.1177/1533317508324272. Epub 2008 Nov 10.

PMID:
19001354
15.

Mechanisms of interferon-beta-induced survival in fetal and neonatal primary astrocytes.

Barca O, Seoane M, Ferré S, Prieto JM, Lema M, Señarís R, Arce VM.

Neuroimmunomodulation. 2007;14(1):39-45. Epub 2007 Aug 15.

PMID:
17700039
16.

Prevalence of multiple sclerosis in Santiago de Compostela (Galicia, Spain).

Ares B, Prieto JM, Lema M, Dapena D, Arias M, Noya M.

Mult Scler. 2007 Mar;13(2):262-4. Epub 2007 Jan 29.

PMID:
17439895
17.

GC-FID determination of cocaine and its metabolites in human bile and vitreous humor.

Fernández P, Aldonza M, Bouzas A, Lema M, Bermejo AM, Tabernero MJ.

J Appl Toxicol. 2006 May-Jun;26(3):253-7.

PMID:
16389661
18.

[SUNCT syndrome secondary to megadolichobasilar anomaly].

Santos-Garcia D, Prieto JM, Blanco-Gonzalez M, Iglesias-Gomez S, Rodriguez-Constenla I, Lema M.

Rev Neurol. 2005 Nov 16-30;41(10):638-9. Spanish. No abstract available.

19.

[Seasonal variations in the outbreaks in patients with multiple sclerosis].

Abella-Corral J, Prieto JM, Dapena-Bolaño D, Iglesias-Gómez S, Noya-García M, Lema M.

Rev Neurol. 2005 Apr 1-15;40(7):394-6. Spanish.

20.

[Time evolution of TNF-alpha, VCAM-1, IL-4, IL-10, neopterin and CD-30 in patients treated with interferon].

Cebrián-Pérez EM, Prieto JM, Lema M, Amigo-Jorrín MC, Iglesias-Gómez S, Noya-García M.

Rev Neurol. 2004 Aug 1-15;39(3):213-7. Spanish.

Supplemental Content

Loading ...
Support Center